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ABSTRACT 
Background: Tuberculosis (TB) incidence in Cameroon is high with 32% of adult 
TB patients, all forms, co-infected with HIV. The Nylon District Hospital in Douala 
runs a centre for the diagnosis and treatment of TB since 2001 and a pioneer Human 
Immunodeficiency Virus (HIV)/Acquired Immune deficiency Syndrome (AIDS) 
management programme at district level since 2000. 
Objective: To determine the prevalence of HIV infection in TB patients from 2003 to 
2006 and to analyse the pattern of TB/HIV co-infection rate over time. 
Design: A retrospective study.
Setting: Nylon District Hospital, Douala, Cameroon.
Results: The prevalence of HIV infection in TB patients was 51.6%. This was greater for 
patients living out of the Nylon Health District (P= 0.001). Smear positive pulmonary 
tuberculosis (SPPT) was the most frequent (65%) form of TB diagnosed but extra-
pulmonary tuberculosis (EPT) and smear negative pulmonary tuberculosis (SNPT) 
were more frequently associated with HIV co-infection (80% and 68.6% respectively). 
While men and women presented equally with TB, women (61.4%) were significantly 
(P< 0.0001) more TB/HIV co-infected than men (42%). The co-infection rate was highest 
among individuals aged 25-44 years (61.4%) and least among the 0-24 years age group 
(22.5%). The increase in TB/HIV co-infection rate is monotonic over time with a stronger 
trend among females aged 25-44 years (P= 0.037) and above 45 years (P= 0.001). 
Conclusion: The NDH selectively attracted HIV positive patients to adhere to their 
HIV programme. The creation of HIV / AIDS treatment units in institutions providing 
TB diagnosis and treatment services will reduce the movement of TB/HIV co-infected 
patients across provinces and health districts as well as enhancing TB/HIV co-infection 
diagnosis and notification. 
INTRODUCTION 
HIV is most potent single risk factor for the 
development of tuberculosis (TB) and is known to 
be responsible for the resurgence of TB worldwide. 
Countries with a high prevalence of HIV also 
have a high incidence of TB hence confirming the 
happy marriage between TB and HIV. In Africa, the 
proportion of TB patients infected with HIV ranges 
from 0.5% in Algeria to 70% in Botswana (1). The 
World Health Organisation (WHO) African region 
has the highest TB burden consistent with the high 
prevalence of the HIV pandemic in the continent 
especially in sub-Saharan Africa. In the year 2000, 
31% of all new TB cases in adults aged 15-49 years 
in Africa were attributable to HIV (2). 
 The impact of HIV on TB is enormous. HIV 
causes a reduction in cellular immunity which is 
indispensable for the host response to TB infection. 
Due to this immune suppression, HIV increases the 
risk of direct progression of primary disease to full 
blown TB as well as increasing the risk of reactivating 
the latent tubercle bacilli (3). HIV negative persons 
with latent TB have a lifetime risk of about 10% of 
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developing active TB (4) whereas in HIV positive 
persons, the risk of 10% is reduced from a lifetime to 
a year or two risks. Therefore HIV causes a general 
increase in the reservoir of infectious TB cases in the 
general population augmenting the potential risk of 
contamination within a community with high HIV 
prevalence even among non HIV patients. 
 On the other hand, TB is the leading cause of 
morbidity and mortality in HIV/AIDS patients 
especially in Africa(6). TB enhances HIV replication 
and hence the natural progression of HIV infection(7). 
As such the immune response to infection by HIV 
patients suffering from active TB is further reduced 
making way for other opportunistic infections to 
develop hence increasing the likelihood of death. 
 With an HIV prevalence of 5.5% in 2004 (female 
to male ratio of 1.7), Cameroon is among African 
countries with a high HIV burden(8). The incidence 
and mortality of all forms of TB increased from 65 and 
19/100,000 population in 1990 to 174 and 23/100,000 
population in 2005 respectively (1). The proportion 
of TB patients aged 15-49 years among People Living 
With HIV/AIDS (PLWH/A) in Cameroon also 
increased from 26% in 2000 (2) to 32% in 2005 (1).
 The centre for the treatment and diagnosis of TB 
at Nylon District Hospital started in April 2001 just 
five months before the beginning of the Medecins 
Sans Frontiers/Switzerland (MSF-CH) Douala 
Project at the same hospital, which aims to provide 
a comprehensive health care to PLWH/ A by treating 
opportunistic infections and providing psychosocial 
support in partnership with the public sector. In April 
2003, the Douala project was expanded to PREvention 
et Traitement Integre du VIh (PRETIVI Project) with 
the addition of anti-retroviral therapy (ARV) to the 
already existing package of services. Some other 
advantages associated with being registered in the 
PRETIVI project were: free medical and psychosocial 
consultations, 100% subvention of hospitalisation 
fee and blood transfusion cost. Healthcare cost for 
destitutes, ARV drugs, drugs for the treatment of 
opportunistic infections and paraclinical examinations 
were subsidised with respect to the patient’s capacity 
to pay. The harmonisation and collaboration between 
the TB and HIV programmes in terms of patient care 
actually began in 2004. 
 Elsewhere, the management of HIV patients in 
Cameroon was only in tertiary or university teaching 
hospitals. The PRETIVI project at the Nylon District 
Hospital was thus a pioneer programme at district 
level in Cameroon. 
 Cameroon being a high burden HIV country, 
studies on the estimation of the HIV prevalence are 
lagging behind as the most recent dates back to 2004 
(8). Bearing in mind the interaction between HIV and 
TB, the national TB/HIV co-infection rate of 32% in 
2005 (1) for all forms of TB in adults is likely to be 
an under estimation as opposed to the co-infection 
rates observed in other high HIV burden countries in 
Africa. Some cities like Douala, Yaounde, Ngaoundere 
and Limbe are known to be hot spots in terms of 
TB/HIV co-infection in Cameroon with rates greater 
than the reported national rates (Noeske J, personal 
communication). 
 The aim of this study was to determine the 
prevalence of HIV infection in TB patients treated 
at the Nylon District Hospital from 2003 to 2006, 
analyse the pattern of TB/HIV co-infection rate over 
time and determine what proportion of TB/HIV 
co-infected patients were registered in both TB and 
HIV programmes. This will provide an orientation 
in integrating TB and HIV treatment centres within 
the same health institutions making reporting and 
notification more efficient. 
MATERIALS AND METHODS 
Setting: Created in 1992 by support from the 
Switzerland government, the Nylon health district 
is one of the six and most populated health districts 
of the city of Douala. It is an urban slum located in 
the south eastern part of the city with an estimated 
population of 400,000 inhabitants distributed over 
700 hectares of land. The basis of its creation was to 
set up a system of community participation in health 
care which could later be implemented in other health 
districts nation wide. 
 It is in this light that the Nylon District Hospital 
which serves as a first line referral unit in the district 
was among the first in the province to host the 
National Tuberculosis Programme (NTP) after its 
reorganisation in 2001. The PRETIVI project was 
the first of its kind to provide comprehensive care 
to PLWH/ A at district level to the over six million 
inhabitants of three neighbouring provinces (Littoral, 
South West and West provinces). The integration of 
both TB and HIV programmes gave the hospital a 
good reputation and attracted a lot of patients. 
 Case detection is passive. Patients who present 
at the hospital with a dry or productive cough for 
at least three weeks are referred to do a sputum test 
(three early morning sputum smear in three days). The 
coughing can be accompanied by other respiratory 
symptoms like haemoptysis, chest pain and dyspnoea 
or general symptoms like weight loss, fever and 
night sweats. Once the clinical suspicion is made, 
a confirmatory diagnosis and treatment follows the 
national guidelines (9). Patients with at least two of 
the three sputum smears positive for acid fast bacilli 
are declared Smear Positive Pulmonary Tuberculosis 
(SPPT). Smear Negative Pulmonary Tuberculosis 
(SNPT) is diagnosed in patients presenting with 
persistent signs and symptoms of TB, two series of a 
negative sputum test at ten days interval and with/
without a suspicious chest X-ray film after receiving 
non specific antibiotic therapy for ten days. Diagnosis 
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of extra-pulmonary tuberculosis (EPT: TB in any other 
location apart from the lungs) is mainly clinical and 
based on the physician’s expertise in identifying the 
signs and symptoms and/or specific para-clinical 
examinations with respect to the location of the 
infection. Patients who had never been diagnosed 
with TB and have never taken TB medications are 
considered new cases. 
 Patients are referred for voluntary counselling 
and testing to the psychosocial department comprising 
of counsellors, social workers and a psychologist. 
The test kits were provided by MSF-CH and cost 
US $2 per test. Rapid antibody testing techniques 
were used in the following pairs with respect to 
the availability: Dermine®  HIV-1/2 test (ABBOT 
Diagnostic Division, Hoofddorp, Netherlands) and 
Immunocomb II Bispot HIV-1/2 (Orgenetics Ltd, 
Israel) or Dermine®  HIV -1/2 test (ABBOT Diagnostic 
Division, Hoofddorp, Netherlands) and Camstix 
HIV-1/2 (Camdiagnostix, Yaounde, Cameroon). A 
person was considered HIV positive if both tests were 
positive. If the first test (Dermine®) was negative, the 
patient was assumed negative and a second test was 
omitted. Undetermined results were sent to the Centre 
Pasteur laboratory in Yaounde for a confirmatory test 
and the results made known to the patients when 
available. The results were given to the patients from 
the 48th hour after post-counselling by workers in the 
psychosocial department. HIV positive patients are 
automatically proposed to join the PRETIVI Project 
during post-counselling. A PRETIVI file is opened for 
patients with a positive response and he/she referred 
for medical consultation. 
Study population and design: It was a retrospective 
study in which all TB patients registered in the 
Nylon District Hospital centre for the diagnosis and 
treatment of TB from 2003 to 2006 were included. The 
TB register was reviewed for information regarding 
socio-demographic factors (age, sex and place of 
residence) and clinical factors (type of TB, HIV status 
and treatment history).
Data analysis: Data was entered and analysed using 
SPSS 14.0 for Windows and Microsoft Office Excel 
2003. After entering of data into SPSS, cleaning 
up was ensured by running frequency tables and 
correcting for any errors and missing values using 
patient treatment cards. Linear regression was used 
to compare trends in TB/HIV co-infection rate using 
Excel after creating dummy variables. The value of R2 
per model was reported. The Chi-square tests (with 
Yates correction when relevant) was used to compare 
groups of categorical variables and the independent 
sample t-test to compare mean ages. A 95% confidence 
interval was calculated and values of P < 0.05 were 
considered significant. 
RESULTS 
There were 998 registered TB cases from 2003 to 2006. 
One hundred and thirty three patients were excluded 
from the analysis: 128 who did not take the HIV 
test and five whose HIV results were inconclusive. 
Four patients with combined SPPT and EPT were 
analysed as SPPT cases. The analysis of 865 patients, 
is presented. 
Figure 1
Prevalence of HIV infection and HIV testing in Nylon District Hospital  
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Characteristics of the patients: Of the 865 patients, 438 
(50.6%) were males. The age ranged from 2 to 75 years. 
The mean age at diagnosis for TB in males [35.2 + 
11.4] was significantly greater (P < 0.0001,95% CI of 
the difference = 1.672 to 4.521) than that of the females 
[32.1 + 9.9]. Individuals aged 25-44 years constituted 
the majority 546(63.1%) of patients followed by the 
0-24 years age group 182 (21%) while the 45+years 
age group was the least affected with 137 (15.8%) 
cases. Most of the patients 752 (86.9%) were newly 
diagnosed TB cases. Nylon residents represented 
only 412(47.6%) of the study population. The most 
frequent form of TB diagnosed was SPPT 562(65%) 
cases, followed by EPT 185 (21.4%) cases and lastly 
SNPT 118 (13.6%) of cases. 
TB/HIV co-infection: The prevalence of HIV infection 
among TB patients (all ages and all forms combined) 
was 51.6% (446 HIV positive cases out of 865 patients). 
The age range of HIV positive patients was 2 to 63 
years. The mean age of HIV positive patients [35.4 + 
8.9] with TB was significantly greater (P <0.0001, 95% 
CI of the difference = 2.231 to 5.069] than that of HIV 
negative patients with TB [31.7 + 12.2]. The TB/HIV 
co-infection rate in adults aged 15-49 years was 52.3% 
(406 HIV positive tests out of 776 tested adults). 
 There is an association between HIV status and 
gender, TB type, age group and health district of 
residence (Table 1). The prevalence of HIV infection 
was significantly (P < 0.0001) higher among female TB 
patients (61.4%) and significantly higher (P = 0.001) 
among TB patients not resident in Nylon Health 
District (57%). The prevalence was lowest among 
the youths aged 0-24 years (22.5%). EPT (80%) and 
SNPT (68.6%) were almost always associated with 
HIV infection. 
Table 1
Characteristics of patients by HIV status 
   Total  
  HIV  number of  
  Positive  patients per  
  cases  category  
Variable and Category  No.  (%)  (T)  P-value
 
Gender     
 Males  184   42  438  
 Females  262   61.4  427  <0.0001 
Health District of Residence    
Nylon Health District  188   45.6  412  
Non Nylon Health District  258   57  453  0.001 
Treatment history New cases  390   51.9   752  
 Old cases  56    49.6  113  0.722 
Age group (years) 0-24  41    22.5  182  
 25-44  335   61.4  546  
 45+  70    51.1  137  <0.0001 
     
TB Type SPPT  217   38.6  562  
 SNPT  81    68.6  118  
 EPT  148   80  185  <0.0001  
P-values from chi square with continuity correction. No. = Number of HIV positive cases per category.
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Trends in prevalence of HIV infection among TB patients: 
Generally there is an upward trend in the prevalence of 
HIV infection in TB patients over time. The prevalence 
of HIV infection is increasing similarly over time in 
both sexes, in patients newly diagnosed with TB as 
well as those with a history of TB and among patients 
resident in and out of the Nylon Health District as 
illustrated by the slopes and P-values in Table 2. 
Among the males, the slope increases similarly over 
time with increases in the age of patients. Meanwhile, 
Table 2
Trends in TB/HIV co-infection rate by study variables
Variable and category  Slope [percent per year] R2 P(slope) 
Gender     
 Males(Ref.)  5.48   * 
 Females  9.27  97.4  0.103
 
Health District of Residence    
Non Nylon Health District(Ref.)  11.73   * 
Nylon Health District   4.73  90  0.114 
    
Treatment History Old cases(Ref.)  3.79   * 
 New cases  8.4  93.7  0.053 
    
Age group/Males 0-24 (Ref.)  1.72   * 
(years) 25-44  5.68   0.483 
 45+  6.57  89.4  0.396 
    
Age group/Females 0-24 (Ref.)  -1.98   * 
(years) 25-44  8.19   0.037 
 45+  20.45  96.1  0.001 
    
TB Type  SNPT(Ref.)  -5.000   * 
 SPPT  4.82   0.192 
 EPT  6.64  84.9  0.132 
R2 = Percentage variation in TB/HIV co-infection rate that can be explained over time per model. 
P (Slope) = P-value for the difference of the slope with respect to the reference category obtained 
from linear regression. Ref. = Reference category. 
the slope of females aged 25-44 years [8.19% per year] 
is significantly greater (P = 0.037) than that of the 0-24 
years [-1.98% per year] reference category. Likewise, 
the slope of females aged 45 years and above  [20.45% 
per year] is significantly greater (P = 0.001) than that 
of the 0-24 years [-1.98% per year] reference category. 
The highest increase in TB/HIV co-infection rate over 
time is among EPT cases but the slope is not different 
from that of the SNPT reference category.
Registration in both TB and HIV programmes: Of the 
466 HIV positive patients with TB, 299(67%) were 
followed up in both TB and HIV programmes (77.9% 
if the 62 TB/HIV co-infected patients in 2003 are 
excluded). In 2003, co-infected patients followed up 
in both programmes were not registered in the TB 
register because of lack of coordination between both 
programmes. 
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DISCUSSION 
This study shows that 51.6% of the TB patients treated 
in the Nylon District Hospital from 2003 to 2006 
were also infected with HIV. There was a monotonic 
increase in the TB/HlV co-infection rate from 2003 to 
2006 with significantly upward trends only among 
females aged 25-44 years and 45 years and above 
age group. Two-thirds of the TB/HIV co-infected 
patients were followed up in both TB and PRETIVI 
programmes. 
 The rate of acceptance of HIV testing with post 
counselling in our study was unusually high (87.2%: 
870 tests done out of 998 registered patients). Caution 
should be taken not to compare this with other 
studies not providing the necessary services and a 
conducive environment for voluntary testing and 
counselling (VTC) having HIV testing acceptance rate 
fluctuating around 50%. The Nylon District Hospital 
has a psychosocial service department with seven 
permanent staff (all MSF-CH: a psychologist, two 
social workers and four counsellors) and a number 
of part-time workers from associations of PLWH/A 
offering VCT among other services. All patients 
referred for HIV testing are received for a general 
health talk before individual counselling. All TB 
patients were systematically sent for HIV testing as 
at 2004. The Thyolo Health District in Malawi with 
a similar setup also has a very high HIV post-testing 
of 87% (10). Therefore under organised conditions a 
district hospital is capable of providing maximal HIV 
testing acceptability levels. 
 SPPT was the most frequent form of TB in 
our study population. Similar findings of a higher 
frequency of infectious TB cases in an era of HIV were 
reported by studies in Sudan (11) and Italy (l2). Most 
patients were newly diagnosed with TB and young 
adults aged 25-44 years constitute a greater majority 
of the patients. The proportion of men and women 
with TB are similar but women are having TB at a 
younger age. This gender difference regarding the 
age at diagnosis of TB may be due to the social roles 
of women in the society. 
 In Douala and other parts of Cameroon, women 
are known to be the ones to care for their sick spouse, 
children and other family members. According to 
the 2004 demographic health survey of Cameroon, 
67.2% of women in Cameroon live in a union (legally 
married or not) and 30% of married women are in a 
polygamous regime. In Cameroon, the median age at 
first marriage for women and men aged 25-49 years 
are 17.6 and 24.9 years respectively [Median age at 
first marriage in Douala for women aged 25-49 years 
and males aged 30-49 years are 20.6 and 27.5 years 
respectively]. The legal age for marriage is 15 years 
for women and 18 years for men in Cameroon (8). 
In this capacity, women are exposed to the risk of 
contracting infectious diseases like TB at a younger age 
from spouses and other family members. Strikingly, 
the TB/HIV co-infection rate in our study population 
was very high and continues to increase. The TB/
HIV co-infection rate of all forms of TB and all ages 
in our study of 51.6% was greater than the national 
co-infection rate of 32% in 2005 yet lower than rates 
of over 60% observed in countries with higher HIV 
burden like South Africa, Swaziland, Zimbabwe, 
Lesotho and Botswana (2). HIV infection modifies the 
association between gender, age group and TB. The 
higher TB/HIV co-infection rate in females and adults 
aged 25-44 years reflect the high prevalence of HIV in 
these populations in Cameroon. The seroprevalence 
of HIV in males and females in the city of Douala are 
3.6% and 5.5% respectively while in Cameroon as a 
whole it is reported to be 8.8% among females aged 
25-44 years and 6.8% among men of the same age 
group but lower in the other age groups (8). Same 
findings but with lower rates were reported by Chum 
et al (13) in Tanzania, Kiwuwa et al in Uganda (l4) 
and Kuaban et al (15) in the Chest medicine tertiary 
hospital in_Yaounde-Cameroon. This was not the 
case in Jamaica where Akpaka et al (16) found that 
TB/HIV co-infection was more prevalent in males 
than females. This difference is probably due to the 
fact that in Africa, transmission of HIV infection is 
mainly heterosexual and women are more vulnerable 
whereas in Europe and the Americas, intravenous 
drug use and homosexual routes of transmission are 
the most common. 
 TB/HIV co-infection was higher in patients 
with EPT and SNPT consistent with other studies 
in Africa (13, 17) affirming the strong relationship 
between HIV infection and the development of EPT 
or SNPT. Nylon residents represent only 47.6% of the 
registered TB patients and the TB/HIV co-infection 
rate was significantly greater among the non Nylon 
residents. Of the 453 non Nylon residents, 431(95.2%) 
lived in the other five health districts of the city of 
Douala (26.5% in Deido Health District, 22.5% in Cite 
de Palmiers Health District, 21.2% in Logbaba Health 
District, 20.8% in New-Bell Health District and 4.2% in 
Bonassama Health District) and 22(4.8%) from other 
provinces. Bonassama Health District is the furthest 
of the five health districts from Nylon Health District. 
Therefore the very high TB/HIV co-infection rate in 
the Nylon District Hospital TB treatment centre is 
due to a selection bias from the pool of mostly HIV 
positive patients coming from all over the city and 
from neighbouring provinces. They were attracted 
to the centre because of the need to benefit from 
an integrated TB and HIV care at a negligible cost. 
Nonetheless, the TB/HIV co-infection rate for Nylon 
residents (45.6%) and non Nylon residents (57%) 
are greater than the national rates over the same 
period. 
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 The upward trend in TB/HIV co-infection rate 
in both males and females over a short period of time 
(four years 2003 to 2006) is an indication that the HIV 
pandemic in the general population of Cameroon is 
far from being contained. Noeske and colleagues did 
a systematic review of reported HIV seroprevalence 
rates in the general adult population and in adults 
aged above 14 years with SPPT in Cameroon and 
found that the TB/HIV co-infection rate increased 
from 2.9% in 1989 to 29% in 2000 (18). Using their 
annual average increase co-infection rate of 2.3%, we 
would expect a TB/HIV co-infection rate of about 
39.7% among patients with SPPT after 16 years (1989 
to 2005 (5) which is similar to our finding of 38.6% 
as opposed to the 2005 national rate of 11% in the 
same group of patients (1) hence supporting our 
hypothesis of a possible under notification in TB/
HIV co-infection rate. Djouffo (19) while studying 
the TB/HIV co-infection rate of the first trimester in 
the twenty six TB diagnosis and treatment centres 
in the Littoral province in Cameroon in 2007, found 
a TB/HIV co-infection rate of 44.2% (423 positive 
out of 957 tested TB patients) all forms and all ages, 
similar to our finding. Up to 774( 44.7%) out of the 
1731 registered patients did not do their HIV test or 
did the test but was not registered in the TB register. 
He also reported that 14 out of the 26 TB treatment 
centres had an HIV testing rate of less than 50%. 
Though HIV testing was free in 11 of the TB treatment 
centres, it cost US $2 to US $6 in ten TB treatment 
centers (19). The non proposal of HIV testing, low 
notification of HIV test results and high cost of HIV 
testing are possible factors likely to explain the low 
reported rate of TB/HIV co-infection in the Littoral 
province in particular and Cameroon at large.
 The upward trend seen only in females aged 25-
44 years and 45 years and above age groups predicts 
a likelihood of female dominance in TB infection in 
the short term. Surprisingly, despite a national HIV 
prevalence of 8.3% in female youths aged 15-24 years 
in 2004, the TB/HIV co-infection rate among females 
of this age group is decreasing probably indicating a 
decrease in the HIV prevalence in this age group. 
Strengths and limitations: The NDH is well known 
through its contribution to the creation of 65 HIV/
AIDS treatment units nationwide by the government. 
In this study, we have used just a portion of the 
considerable data found in the hospital to elucidate 
the important role district hospitals can play in the 
diagnosis and follow up of TB patients infected with 
HIV/AIDS if they are provided with the necessary 
human and material resources. 
 This study is the first of its kind since the 
opening of the NDH tuberculosis treatment centre 
in 2001. No such detailed evaluation has ever been 
done. Nonetheless we can identify the following 
limitations: 
(i)  Evaluating TB trends in the Nylon District Hospital 
treatment centre alone is not representative 
enough to recommend the creation of an HIV 
treatment unit in every TB treatment centre 
around the country despite the severe impact 
of HIV on TB elucidated by our study. More 
evaluations of the same type need to be done in 
other TB treatment centres. More so, the study 
period is short to clearly elucidate different time 
trend series. 
(ii)  Over the years there is likely to be an increase in 
the ability of physicians to clinically suspect and 
diagnose TB especially SNPT and EPT and of 
laboratory technicians to perform sputum smear 
tests. The national tuberculosis programme 
diagnostic criteria remained the same for all of 
the three forms of TB during the study period 
therefore any overestimation in diagnosis will 
be non differential. Though doing the same 
analysis only among SPPT patients would be 
more convincing, the contribution of SNPT and 
EPT in the TB/HIV co-infection burden in the 
Nylon Health District can not be ignored reason 
why we included these patients in our study 
population. 
(iii)  Of the 128 TB patients who did not do an HIV 
test, 79(61.7%) were males. This may introduce 
a non response bias in the acceptability of HIV 
testing and gender. Individuals aged 25-44 
years constituted the majority of this population 
(43.8%) similar to those who accepted to do the 
HIV test. 
In conclusion, tuberculosis is a public health problem 
in the NHD and will remain so for quite sometime 
so far as the necessary measures are not taken to 
improve on the prevention of the HIV pandemic 
which is fueling TB incidence. The burden in the 
number of TB cases at the Nylon District Hospital 
is not only due to the increasing number of TB/HIV 
co-infected patients from other districts but also from 
within the Nylon Health District. One out of every 
two TB patients treated in the hospital from 2003 to 
2006 also had HIV. The working population aged 
25-44 years is the most affected but a clear upward 
trend over time is seen only among females of this 
age group hence a risk of female dominance in TB 
in the short term. 
 We therefore recommend that, the same 
evaluation should be carried out in other TB 
treatment centres around the country to provide a 
basis for the creation of HIV/AIDS treatment units 
in hospitals acting as TB diagnosis and treatment 
centres. Meanwhile, all TB treatment centres should 
be provided with the necessary resources to do HIV 
testing and reinforce notification of results. 
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